The two assessors, Mark Hallett (NIH) and James Rowe (University of Cambridge) had a truly enjoyable scientific discussion with Allan, making DRCMR’s first virtual defense very real.

Thanks to those who joined the defense via Zoom and to Finn Sellebjerg who chaired the defense.

And congratulations to Allan!!